News
Foresee Pharma begins patient dosing in phase 2 WINDWARD study of mirivadelgat to treat pulmonary hypertension-associated interstitial lung disease: Taipei, Taiwan Friday, May 16, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback